MEDFAR has acquired AlloMia, a Québec-based company specializing in artificial intelligence (AI) health technology. The acquisition was announced on October 14, 2026. The financial terms of the transaction were not disclosed.
AlloMia develops AI-powered conversational agents designed to manage patient calls in primary care clinics. MEDFAR, a health technology company known for its MYLE electronic medical record (EMR), stated that this is its second AI acquisition in less than two years and the fourth AI feature integrated into its MYLE platform.
The acquisition aims to extend MYLE's integrated intelligence to patient calls, in addition to clinical and administrative workflows. AlloMia's virtual agent technology responds instantly to calls, processes patient requests, books appointments directly into clinic schedules, and routes calls to the appropriate resource. This system is intended to reduce waiting times and allow administrative staff to focus on tasks requiring human intervention. Since March 2026, several MYLE clinics have participated in a pilot project with AlloMia, where approximately 50% of calls in recently deployed clinics are fully handled by the agent.
Elias Farah, President of MEDFAR, stated that the acquisition of AlloMia marks a new step in the company's vision of integrating AI at every stage of the patient journey, from the initial phone contact to clinical work. Sitech Lim, co-founder and CEO of AlloMia, noted that the company was created to alleviate administrative burdens and provide care teams more time for the human aspect of care.
AlloMia's intelligent telephony will be integrated directly into MYLE, complementing existing AI capabilities such as Scribe AI for clinical documentation, AI form filling, and AI indexing for clinical documents. Patrick Issid, Chief R&D and Innovation Officer at MEDFAR, explained that the goal is to rethink the capabilities of an EMR by integrating intelligence across the entire platform.
The AlloMia team will join MEDFAR, contributing expertise in large language models, AI solution development, and AI agent experience design. MEDFAR will offer AlloMia to all clinics using MYLE, and the agent will also integrate with Plexia and Medgen EMRs.